The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance
Journal of Magnetic Resonance Imaging · 2026-09 · 64 (3) · 722-735
DOI: 10.1002/jmri.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 29.05.2026. Verfasst von Jianwei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Ca…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Joint Funds for the Innovation of Science and Technology, Fujian Province, Fujian Provincial Natural Science Foundation of China, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Background
MRI is sensitive for detecting hepatocellular carcinoma (HCC), but its routine use is hindered by low accessibility.
Purpose
To evaluate the performance of non‐contrast abbreviated MRI (NC‐AMRI) alone and in combination with alpha‐fetoprotein (AFP) and protein induced by vitamin K absence II (PIVKA‐II) compared to a complete MRI protocol for intrahepatic recurrent HCC detection. Study Type Retrospective. Population 190 patients (male = 167, mean age 56.7 ± 11.2 years) undergoing post‐hepatectomy MRI surveillance, including 88 with recurrent HCCs. Field Strength/Sequence T2‐weighted fast spin echo (conventional and PROPELLER), diffusion‐weighted imaging (DWI), and dynamic T1‐weighted gradient echo sequences at 1.5 T and 3.0 T. Assessment The NC‐AMRI set consisted of T2WI and DWI data and was extracted from the complete MRI study. Three radiologists independently evaluated the presence of recurrent HCC in two separate reading sessions (NC‐AMRI and complete MRI). Pairwise comparisons were then made among three strategies: a combination of NC‐AMRI, AFP, and PIVKA‐II; NC‐AMRI alone; and complete MRI. Statistical Tests The diagnostic performance of the three strategies was compared using a marginal logistic regression with generalized estimating equations and McNemar test. Significance level was p < 0.05.
Results
The sensitivity of NC‐AMRI was not significantly different to that of complete MRI for detecting recurrent HCC (Reviewer 1: 94.3% vs. 95.5%, p = 0.655; Reviewer 2: 96.6% vs. 96.6%, p > 0.999; Reviewer 3: 95.5% vs. 94.3%, p = 0.655), including small and medium size HCCs ( p > 0.999 for all comparisons). Adding tumor markers to NC‐AMRI did not significantly improve HCC detection compared to NC‐AMRI alone or complete MRI. Data Conclusion NC‐AMRI demonstrated no significant difference in diagnostic performance compared to that of complete MRI in detecting intrahepatic recurrent HCCs, including small‐sized lesions. Additionally, the incorporation of AFP and PIVKA‐II did not significantly improve the diagnostic sensitivity of NC‐AMRI. Evidence Level 3. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, China.
- Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospital (Fujian Branch of Fudan U…
- Department of Interventional Radiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
ORCID-Profile: Jianwei Chen, Yuemin Zhu, Dechun Zheng, Zhuting Fang
Förderung
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Fujian Provincial Natural Science Foundation of China
- Fujian Provincial Health Technology Project
- Startup Fund for Scientific Research, Fujian Medical University
- National Key Research and Development Program of China
Zitieren
APA
Chen, J., Zhu, Y., Zheng, D., Wen, L., Wu, J., Yue, Q., & Fang, Z. (2026). The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance. Journal of Magnetic Resonance Imaging, 64(3), 722-735. https://doi.org/10.1002/jmri.70356
Vancouver
Chen J, Zhu Y, Zheng D, Wen L, Wu J, Yue Q, et al. The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance. Journal of Magnetic Resonance Imaging. 2026;64(3):722-735. doi:10.1002/jmri.70356
BibTeX
@article{Chen2026,
author = {Chen, Jianwei and Zhu, Yuemin and Zheng, Dechun and Wen, Liting and Wu, Juyi and Yue, Qiuyuan and Fang, Zhuting},
title = {The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
volume = {64},
number = {3},
pages = {722--735},
doi = {10.1002/jmri.70356}
}
EUVIMED